But they added shadows to the spotlight
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
You might already recognize some of the brand names in this class, including Ozempic, Wegovy, Mounjaro, and Rybelsus
The SURMOUNT-1 trial for tirzepatide showed average weight loss of 15% of starting body weight at 36 weeks (roughly 8.5 months)
Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will
The use of prazosin, an 1-adrenergic receptor blocker, showed that the ability of GLP-1RAs to reduce TNF- in plasma was disrupted, signifying the vital role of 1-adrenergic receptors in the anti-inflammatory action of GLP-1RAs